SCHEMBL20792369

C=CCOP(=O)(OCCC#N)O[C@H]1[C@@H](F)[C@H](n2cnc3c(NC(=O)c4ccccc4)ncnc32)O[C@@H]1COP(=O)(OCCC#N)O[C@@H]1C(O[Si](C)(C)C(C)(C)C)[C@@H](CO)O[C@H]1n1nnc2c(C(=O)OC)cccc21

nearest known ligand 0.39

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	P2RY12	Q9H244	13/20	0.35

▸	DNPH1	O43598	3/20	0.34

▸	GAPDH	P04406	1/20	0.33

▸	P2RY2	P41231	1/20	0.33

▸	P2RY1	P47900	1/20	0.33

▸	P2RY6	Q15077	1/20	0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL22220013	1.00	P2RY12 (0.35)	P2RY12DNPH1GAPDHP2RY2P2RY1
SCHEMBL22220012	0.97	P2RY12 (0.33)	P2RY12DNPH1GAPDHP2RY2P2RY1
SCHEMBL25688843	0.94	P2RY12 (0.38)	P2RY12DNPH1GAPDHP2RY2P2RY1
SCHEMBL22220008	0.94	P2RY12 (0.37)	P2RY12DNPH1GAPDHP2RY2P2RY1
SCHEMBL20792499	0.94	P2RY12 (0.37)	P2RY12DNPH1GAPDHP2RY2P2RY1
SCHEMBL25688845	0.91	P2RY12 (0.36)	P2RY12DNPH1GAPDHP2RY2P2RY1
SCHEMBL22219998	0.89	P2RY12 (0.35)	P2RY12DNPH1GAPDHP2RY2P2RY1
SCHEMBL25688848	0.88	P2RY12 (0.40)	P2RY12DNPH1GAPDHP2RY2P2RY1
SCHEMBL25693011	0.88	P2RY12 (0.34)	P2RY12DNPH1GAPDHP2RY2P2RY1
SCHEMBL24321944	0.85	P2RY12 (0.38)	P2RY12DNPH1P2RY2P2RY1P2RY6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
WO-2019046498-A1	CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS	BRISTOL-MYERS SQUIBB COMPANY (US)	2019-03-07	—	—	WO	disclosed